Kanzawa F, Matsushima Y, Ishihara J, Hoshi A, Ohba T, Watanabe K
J Pharmacobiodyn. 1986 Aug;9(8):688-93. doi: 10.1248/bpb1978.9.688.
A series of twenty six 5'-substituted FdUMP (5-fluoro-2'-deoxyuridine 5'-monophosphate) have been evaluated for their inhibitory effects on the proliferation of murine lymphoma L5178Y cells sensitive or resistant to FUdR (5-fluoro-2'-deoxyuridine). 5'-Octylphenylene-FdUMP was the most active among these active derivatives against the parent cell line (L5178Y/P). Several other FdUMP derivatives also proved as potent as FUdR in their antiproliferating activity on the L5178Y/P cell line. Activity of these derivatives was decreased considerably by a substituent with a long aliphatic chain and the introduction of acyl groups on the C-3' position. Eicosyl-FdUMP was found to show no or low cross-resistance on the L5178Y/FUdR subline which was about 19 000-fold resistant to FUdR compared with the parent cell line. This derivative might penetrate cell membrane in an intact form and be converted into FdUMP by a phosphodiesterase inside the cell, because an anabolic enzyme, deoxyuridine kinase, was defective in cells of the L5178Y/FUdR subline. The derivatives were promising as antitumor agents for the treatment of relapsed patients following 5-fluorouracil therapy.
对一系列26种5'-取代的FdUMP(5-氟-2'-脱氧尿苷5'-单磷酸)进行了评估,以研究它们对氟尿嘧啶脱氧核苷(FUdR,5-氟-2'-脱氧尿苷)敏感或耐药的小鼠淋巴瘤L5178Y细胞增殖的抑制作用。在这些活性衍生物中,5'-辛基亚苯基-FdUMP对亲本细胞系(L5178Y/P)的活性最强。其他几种FdUMP衍生物在对L5178Y/P细胞系的抗增殖活性方面也被证明与FUdR一样有效。这些衍生物的活性因带有长脂肪链的取代基以及在C-3'位引入酰基而显著降低。发现二十烷基-FdUMP对L5178Y/FUdR亚系没有或仅有低交叉耐药性,该亚系对FUdR的耐药性比亲本细胞系高约19000倍。这种衍生物可能以完整形式穿透细胞膜,并在细胞内被磷酸二酯酶转化为FdUMP,因为合成代谢酶脱氧尿苷激酶在L5178Y/FUdR亚系的细胞中存在缺陷。这些衍生物有望作为抗肿瘤药物用于治疗5-氟尿嘧啶治疗后复发的患者。